ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 (“Aspen” or “the Company”) ASPEN’S RESULTS FOR THE SIX MONTHS ENDED 31st DECEMBER 2023 AND RESULTS PRESENTATION Shareholders are advised that Aspen intends releasing its results for the six months ended 31st December 2023 on Monday, 4th March 2024 on SENS at 13:00pm (SAST, GMT+2) with a presentation to members of the investment community in-person at the Bank of America Sun City conference and via webcast on Tuesday, 5th March 2024 at 08:30am (SAST, GMT+2). All interested stakeholders are invited to watch the live webcast which can be accessed using the following link: https://www.corpcam.com/Aspen05032024. In-person attendees are requested to RSVP using the following link: https://aspenpharmaforms.com/view.php?id=31392. The slides accompanying the presentation will be available on the Aspen website (www.aspenpharma.com) from the home page shortly before the commencement of the presentation on Tuesday, 5th March 2024. A playback of the webcast will be made available on our website approximately 2 hours after the presentation. Durban 31 January 2024 Sponsor: Investec Bank Limited